Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Cash & Current Investments (2016 - 2025)

Proto Labs' Cash & Current Investments history spans 15 years, with the latest figure at $128.1 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 24.28% year-over-year to $128.1 million; the TTM value through Dec 2025 reached $128.1 million, up 24.28%, while the annual FY2025 figure was $128.1 million, 24.28% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $128.1 million at Proto Labs, up from $119.2 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $128.1 million in Q4 2025 and bottomed at $60.2 million in Q2 2021.
  • The 5-year median for Cash & Current Investments is $91.6 million (2023), against an average of $91.8 million.
  • The largest annual shift saw Cash & Current Investments tumbled 56.89% in 2021 before it skyrocketed 31.5% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $77.5 million in 2021, then increased by 3.38% to $80.1 million in 2022, then grew by 28.3% to $102.8 million in 2023, then increased by 0.28% to $103.1 million in 2024, then rose by 24.28% to $128.1 million in 2025.
  • Per Business Quant, the three most recent readings for PRLB's Cash & Current Investments are $128.1 million (Q4 2025), $119.2 million (Q3 2025), and $103.2 million (Q2 2025).